Atea Pharmaceuticals (AVIR) Amortizatization of Intangibles (2022 - 2026)

Atea Pharmaceuticals (AVIR) recorded quarterly Amortizatization of Intangibles of $581000.0 in Q1 2026, down 28.09% quarter-over-quarter from $808000.0 in Q4 2025, and down 66.61% on a YoY basis from $1.7 million in Q1 2025.

Atea Pharmaceuticals (AVIR) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends

Atea Pharmaceuticals' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $581000.0 for Q1 2026.

  • In Q1 2026, Amortizatization of Intangibles fell 66.61% year-over-year to $581000.0; the TTM figure through Mar 2026 stood at $3.8 million (down 62.42% YoY), while the FY2025 annual figure was $4.9 million, down 58.18% from the prior year.
  • Amortizatization of Intangibles was $581000.0 for Q1 2026 at Atea Pharmaceuticals, down from $808000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $7.9 million in Q4 2022 to a low of $581000.0 in Q1 2026.
  • Historically, Amortizatization of Intangibles has averaged $2.9 million across 5 years, with a median of $2.9 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles increased 12.99% in 2024, then sank 70.22% in 2025.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $7.9 million in 2022, then tumbled by 45.21% to $4.3 million in 2023, then plunged by 37.56% to $2.7 million in 2024, then tumbled by 70.22% to $808000.0 in 2025, then declined by 28.09% to $581000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $581000.0 (Q1 2026), $808000.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 13,267.00
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Atea Pharmaceuticals 347.28 Mn 347.28 Mn - 581,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 581,000.00
Mar 31, 2026 581,000.00
Dec 31, 2025 808,000.00
Dec 31, 2025 808,000.00
Sep 30, 2025 1.08 Mn
Sep 30, 2025 1.08 Mn
Jun 30, 2025 1.32 Mn
Jun 30, 2025 1.32 Mn
Mar 31, 2025 1.74 Mn
Mar 31, 2025 1.74 Mn
Dec 31, 2024 2.71 Mn
Dec 31, 2024 2.71 Mn
Sep 30, 2024 2.60 Mn
Sep 30, 2024 2.60 Mn
Jun 30, 2024 3.02 Mn
Jun 30, 2024 3.02 Mn
Mar 31, 2024 3.49 Mn
Mar 31, 2024 3.49 Mn
Dec 31, 2023 4.35 Mn
Dec 31, 2023 4.35 Mn